SYNLOGIC, INC. Preferred Stock, Shares Authorized
SYNLOGIC, INC. (SYBX) had Preferred Stock, Shares Authorized of 5.00 million shares as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Balance Sheet › Equity › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2019-11-12
- 2019-09-30: Preferred Stock, Shares Authorized 5.00M shares.
- 2019-06-30: Preferred Stock, Shares Authorized 5.00M shares.
- 2019-03-31: Preferred Stock, Shares Authorized 5.00M shares.
- 2018-12-31: Preferred Stock, Shares Authorized 5.00M shares.
| Period end | Preferred Stock, Shares Authorized |
|---|---|
| 2019-09-30 | 5.00M shares 10-Q · filed 2019-11-12 |
| 2019-06-30 | 5.00M shares 10-Q · filed 2019-08-08 |
| 2019-03-31 | 5.00M shares 10-Q · filed 2019-05-09 |
| 2018-12-31 | 5.00M shares 10-Q · filed 2019-11-12 |
| 2018-09-30 | 5.00M shares 10-Q · filed 2018-11-13 |
| 2018-06-30 | 5.00M shares 10-Q · filed 2018-08-09 |
| 2018-03-31 | 5.00M shares 10-Q · filed 2018-05-15 |
| 2017-12-31 | 5.00M shares 10-K · filed 2019-03-12 |
| 2017-09-30 | 5.00M shares 10-Q · filed 2017-11-13 |
| 2017-06-30 | 5.00M shares 10-Q · filed 2017-08-04 |
| 2017-03-31 | 5.00M shares 10-Q · filed 2017-05-09 |
| 2016-12-31 | 5.00M shares 10-K · filed 2018-03-20 |
| 2016-09-30 | 5.00M shares 10-Q · filed 2016-11-10 |
| 2016-06-30 | 5.00M shares 10-Q · filed 2016-08-15 |
| 2016-03-31 | 5.00M shares 10-Q · filed 2016-05-12 |
| 2015-12-31 | 5.00M shares 10-K · filed 2017-03-15 |
| 2015-10-06 | 5.00M shares 10-K · filed 2016-03-30 |
| 2014-12-31 | 0.00 shares 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |